Strut Health review
Some of the lowest compounded pricing on this masthead, oral or injectable — filed, like Direct Meds, with a caveat we won't bury: a February 2026 FDA warning letter for misbranding. The prices are real; so is the regulatory flag.
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Strut Health at a glance
- Semaglutide
- $149/mo (injectable) · $99/mo (oral lozenge)
- Tirzepatide
- $325/mo standard ($199/mo on auto-refill)
- Coverage
- Multi-state (state list not published)
- Brand-name
- Compounded only
How we scored Strut Health
Each score comes out of Strut Health's published pricing, disclosures and oversight, and the six combine into the 73/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Fair value once you read past any teaser rate or plan structure.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- July 2026
- Confidence
- medium
- Primary source
- struthealth.com
$149 for the injectable and $99 for an oral lozenge, with tirzepatide at $325, or $199 if you accept auto-refill. Physician-owned, which counts for something. It also carries a February 2026 FDA warning letter for misbranding: its labeling implied Strut was the compounder, and its site implied the products were FDA-approved.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Oral semaglutide | $99 | Oral lozenge (auto-refill)$99 for a 30-day supply, with a 21% auto-refill saving advertised against the same $99 floor. A sublingual lozenge — a different product from the weekly injection. |
| Compounded semaglutide | $149 | Injectable (auto-refill)$149 for a monthly vial. Strut advertises a 13% auto-refill saving but prints the same $149 as its auto-refill floor. |
| Oral tirzepatide | $199 → $239 | Oral lozenge (30-day)$239 for a 30-day supply, or as low as $199/mo on auto-refill (17% off). Needle-free lozenge. |
| Compounded tirzepatide | $199 → $325 | Injectable (30-day)$325 for a 30-day supply, or as low as $199/mo on auto-refill (Strut prints a 14% auto-refill saving). Re-read from the product page 2026-08-09; the /mens-weight-loss listing cannot be used for this because its price blocks sit next to the following card's title. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Strut Health's public disclosures at last review and change often; confirm the current number on Strut Health's own site.
What we like
- Low flat-rate pricing, oral or injectable, on both semaglutide and tirzepatide
- Physician-owned (founder Simal Patel, MD), with free follow-up care included
- Under-the-tongue lozenge options for a needle-averse start
The caveats
- February 2026 FDA warning letter for misbranding compounded GLP-1 products
- Named pharmacy partners and the exact state list aren't disclosed publicly
- The lowest prices require enrolling in auto-refill; standard prices are less clear
- Cancellation friction is a recurring theme in third-party reviews; no maternal framing
Strut Health for mothers: our verdict
Some of the lowest compounded pricing on this masthead, oral or injectable — filed, like Direct Meds, with a caveat we won't bury: a February 2026 FDA warning letter for misbranding. The prices are real; so is the regulatory flag. It runs about $149/month, flat across every dose — toward the affordable end of what we track.
We weigh Strut Health the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Strut Health actually costs
- Oral semaglutide — Oral lozenge (auto-refill): $99/mo
- Compounded semaglutide — Injectable (auto-refill): $149/mo
- Oral tirzepatide — Oral lozenge (30-day): $199 to start, then $239/mo
- Compounded tirzepatide — Injectable (30-day): $199 to start, then $325/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications Strut Health prescribes
Strut Health prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Strut Health fits — and where it doesn't — for mothers
Worth it if…
- you want a real clinician reading your history around the real monthly cost once the dose climbs, not an auto-approving quiz.
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you want frictionless cancellation — the fine print here is where the complaints cluster.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Strut Health is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Listed for transparency. Read the FDA warning letter in full before you weigh Strut's low prices against a cleaner-terms provider.
Alternatives to Strut Health
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Strut Health
Head-to-head & alternatives
Strut Health, answered
- Can a mother trust Strut Health?
- We keep Strut on the masthead for transparency, and the caveat is heavy: a February 2026 FDA warning letter cited it for misbranding — the 'Strut' label implied Strut itself was the compounder, and website claims implied the compounded products were FDA-approved when they aren't. It's physician-owned (founder Simal Patel, MD) and prices are low, but for most mothers a clean regulatory record is worth more than a few dollars saved. Read the warning letter before you weigh it.
- What does Strut Health actually charge?
- Strut posts flat, all-dose prices, with the lowest figures tied to enrolling in auto-refill: oral semaglutide as low as $99/month, injectable semaglutide as low as $149, and tirzepatide from $199 (auto-refill) up to $325 standard for the injectable. The 'as low as' framing means the auto-refill discount is doing real work, and the standard non-refill prices aren't always clearly posted — confirm the exact number for your plan before you commit.
- Is Strut's oral option a real alternative to the shot?
- Strut offers under-the-tongue lozenge forms of both semaglutide and tirzepatide, which is a genuine draw for a needle-averse mother. Set expectations, though: sublingual delivery of these peptides is far less studied than the injections the pivotal trials actually used, so treat it as a convenience option rather than a proven equal to the shot — and no GLP-1 is established as safe while breastfeeding, whatever the route.
Pricing, states and verification reflect Strut Health's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.